Q2 2023

Filed Aug 8, 2023 · 10-Q · 39 days after period end · 0001558370-23-013763

Q2 2023 · 10-Q

Revenue

$3.92M

no prior Q2 2022 on file

Net Income

-$7.37M

N/M vs Q2 2022

EPS Diluted

-$0.29

N/M vs Q2 2022

Operating Income-$7,747,259N/M

Operating Cash Flow

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$3.92M	—	$204.08K	$49.86K
Net Income	-$7.37M	-$7.11M	-$4.75M	-$3.48M
EPS Diluted	-$0.29	-$0.29	-$0.21	-$0.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Capricor Therapeutics, Inc. · CIK 1133869 · Engraved from SEC EDGAR